Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01271465 · ClinicalTrials.gov registry record

Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant

A clinical trial of Kidney Transplantation, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
24
Enrollment target
1
Study location

NCT01271465: Completed study of Kidney Transplantation, sponsored by Weill Medical College of Cornell University.

NCT01271465 is a study of Kidney Transplantation that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants, below the 267-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01271465, a study of Kidney Transplantation, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if substances measured in a small piece of the donor organ predicts how well the organ will function in the recipient after transplant. We will be testing blood, urine, and biopsy tissue samples in this study. The research team will be looking at different risk factors in the donor organ that predict how well the kidney will do in the recipient.

Conditions Studied

Interventions

  • PROCEDURE Kidney Biopsy

Study Locations (1)

New York

  • Weill Cornell Medical College - New York

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2010-09
Est. Completion 2021-09-18

What the finished NCT01271465 record still lists

NCT01271465 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 267-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Kidney Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Kidney Biopsy is the first listed.

NCT01271465 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01271465 about?

NCT01271465 is a clinical study titled "Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant". The purpose of this study is to see if substances measured in a small piece of the donor organ predicts how well the organ will function in the recipient after transplant. We will be testing blood, urine, and biopsy tissue samples in this study. The research team will be looking at different risk fa...

What is the current status of trial NCT01271465?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2010-09. Estimated completion is 2021-09-18.

What conditions does trial NCT01271465 study?

This clinical trial studies the following conditions: Kidney Transplantation.

What interventions are being tested in trial NCT01271465?

The interventions under investigation include: Kidney Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01271465?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01271465 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01271465's enrollment target sits among peer trials

24 30th of 33 higher than 4 of 33 other Kidney Transplantation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Kidney Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01271465, the US trial registry maintained by the National Library of Medicine. NCT01271465 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.